Johnson & Johnson ordered to pay $55 million in talc-powder trial

Johnson & Johnson was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer. The verdict, which J&J plans to appeal, was the second straight trial loss for the company, which is facing about 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products' cancer risks. Following a three-week trial in Missouri state court, jurors deliberated for about a day before returning a verdict for Gloria Ristesund.

Read more: 
Johnson & Johnson ordered to pay $55 million in talc-powder trial